{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:26:46Z","timestamp":1794472006241,"version":"4.9.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 32371451, 22205151 and 32201148"],"award-info":[{"award-number":["No. 32371451, 22205151 and 32201148"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-025-01518-1","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:03:10Z","timestamp":1761123790000},"page":"1096-1112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A HO-1 gene knockout using a NanoCRISPR scaffold suppresses metastasis in mouse models"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7159-2336","authenticated-orcid":false,"given":"Ning","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9236-9160","authenticated-orcid":false,"given":"Zichao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6330-5720","authenticated-orcid":false,"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9229-9529","authenticated-orcid":false,"given":"Qinjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2517-5790","authenticated-orcid":false,"given":"Xiaogang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2913-0891","authenticated-orcid":false,"given":"Changyang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"1518_CR1","doi-asserted-by":"publisher","first-page":"13454","DOI":"10.1021\/acs.chemrev.1c00381","volume":"121","author":"TC Pham","year":"2021","unstructured":"Pham, T. C., Nguyen, V. N., Choi, Y., Lee, S. & Yoon, J. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy. Chem. Rev. 121, 13454\u201313619 (2021).","journal-title":"Chem. Rev."},{"key":"1518_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1021\/acs.nanolett.0c03731","volume":"21","author":"M Overchuk","year":"2021","unstructured":"Overchuk, M. et al. Subtherapeutic photodynamic treatment facilitates tumor nanomedicine delivery and overcomes desmoplasia. Nano Lett. 21, 344\u2013352 (2021).","journal-title":"Nano Lett."},{"key":"1518_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","volume":"17","author":"X Li","year":"2020","unstructured":"Li, X., Lovell, J. F., Yoon, J. & Chen, X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat. Rev. Clin. Oncol. 17, 657\u2013674 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1518_CR4","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1126\/sciadv.abd1631","volume":"6","author":"W Yang","year":"2020","unstructured":"Yang, W. et al. Size-transformable antigen-presenting cell-mimicking nanovesicles potentiate effective cancer immunotherapy. Sci. Adv. 6, 1631 (2020).","journal-title":"Sci. Adv."},{"key":"1518_CR5","doi-asserted-by":"publisher","first-page":"1900927","DOI":"10.1002\/adma.201900927","volume":"31","author":"Z Meng","year":"2019","unstructured":"Meng, Z. et al. Light-triggered in situ gelation to enable robust photodynamic-immunotherapy by repeated stimulations. Adv. Mater. 31, 1900927 (2019).","journal-title":"Adv. Mater."},{"key":"1518_CR6","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1126\/sciadv.abn2941","volume":"8","author":"Y Guo","year":"2022","unstructured":"Guo, Y. et al. Copackaging photosensitizer and PD-L1 siRNA in a nucleic acid nanogel for synergistic cancer photoimmunotherapy. Sci. Adv. 8, 2941 (2022).","journal-title":"Sci. Adv."},{"key":"1518_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1021\/acscentsci.2c00227","volume":"8","author":"Z Huang","year":"2022","unstructured":"Huang, Z. et al. Rational vaccinology: harnessing nanoscale chemical design for cancer immunotherapy. ACS Cent. Sci. 8, 692\u2013704 (2022).","journal-title":"ACS Cent. Sci."},{"key":"1518_CR8","doi-asserted-by":"publisher","first-page":"2206659","DOI":"10.1002\/adma.202206659","volume":"34","author":"L Shi","year":"2022","unstructured":"Shi, L. et al. An activity-based photosensitizer to reverse hypoxia and oxidative resistance for tumor photodynamic eradication. Adv. Mater. 34, 2206659 (2022).","journal-title":"Adv. Mater."},{"key":"1518_CR9","doi-asserted-by":"publisher","first-page":"202303093","DOI":"10.1002\/anie.202303093","volume":"62","author":"JK Li","year":"2023","unstructured":"Li, J. K., Zhang, M. Y., Zeng, L., Huang, L. & Wang, X. Y. NIR-absorbing B, N-heteroarene as photosensitizer for high-performance NIR-to-blue triplet\u2013triplet annihilation upconversion. Angew. Chem. Int. Ed. 62, 202303093 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"1518_CR10","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1021\/jacs.0c12851","volume":"143","author":"HB Cheng","year":"2021","unstructured":"Cheng, H. B. et al. Protein-activatable diarylethene monomer as a smart trigger of noninvasive control over reversible generation of singlet oxygen: a facile, switchable, theranostic strategy for photodynamic-immunotherapy. J. Am. Chem. Soc. 143, 2413\u20132422 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"1518_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41551-018-0261-7","volume":"3","author":"K Yamagishi","year":"2019","unstructured":"Yamagishi, K. et al. Tissue-adhesive wirelessly powered optoelectronic device for metronomic photodynamic cancer therapy. Nat. Biomed. Eng. 3, 27\u201336 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"1518_CR12","first-page":"040971","volume":"10","author":"R Gatenby","year":"2020","unstructured":"Gatenby, R. & Brown, J. The evolution and ecology of resistance in cancer therapy. Cold Spring Harb. Perspect. Med. 10, 040971 (2020).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"1518_CR13","doi-asserted-by":"publisher","first-page":"2206121","DOI":"10.1002\/adma.202206121","volume":"34","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Tumor selective metabolic reprogramming as a prospective PD-L1 depression strategy to reactivate immunotherapy. Adv. Mater. 34, 2206121 (2022).","journal-title":"Adv. Mater."},{"key":"1518_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack, I. & Shaw, A. T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 15, 81\u201394 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1518_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","volume":"20","author":"A Kalbasi","year":"2020","unstructured":"Kalbasi, A. & Ribas, A. Tumour-intrinsic resistance to immune checkpoint blockade. Nat. Rev. Immunol. 20, 25\u201339 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1518_CR16","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nmeth.2649","volume":"10","author":"P Mali","year":"2013","unstructured":"Mali, P., Esvelt, K. M. & Church, G. M. Cas9 as a versatile tool for engineering biology. Nat. Methods 10, 957\u2013963 (2013).","journal-title":"Nat. Methods"},{"key":"1518_CR17","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR\u2013Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"1518_CR18","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41580-019-0131-5","volume":"20","author":"A Pickar-Oliver","year":"2019","unstructured":"Pickar-Oliver, A. & Gersbach, C. A. The next generation of CRISPR\u2013Cas technologies and applications. Nat. Rev. Mol. Cell Biol. 20, 490\u2013507 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1518_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41565-019-0381-6","volume":"14","author":"J Xu","year":"2019","unstructured":"Xu, J. et al. Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer. Nat. Nanotechnol. 14, 388\u2013397 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"1518_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nbt.2884","volume":"32","author":"H Yin","year":"2014","unstructured":"Yin, H. et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. 32, 551\u2013553 (2014).","journal-title":"Nat. Biotechnol."},{"key":"1518_CR21","doi-asserted-by":"publisher","first-page":"18756","DOI":"10.1021\/jacs.2c07913","volume":"144","author":"C Huang","year":"2022","unstructured":"Huang, C., Han, Z., Evangelopoulos, M. & Mirkin, C. A. CRISPR spherical nucleic acids. J. Am. Chem. Soc. 144, 18756\u201318760 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"1518_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-015-0221-1","volume":"15","author":"KO Alfarouk","year":"2015","unstructured":"Alfarouk, K. O. et al. Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell Int. 15, 71 (2015).","journal-title":"Cancer Cell Int."},{"key":"1518_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121815","volume":"290","author":"L Li","year":"2022","unstructured":"Li, L. et al. Multifunctional light-activatable nanocomplex conducting temperate-heat photothermal therapy to avert excessive inflammation and trigger augmented immunotherapy. Biomaterials 290, 121815 (2022).","journal-title":"Biomaterials"},{"key":"1518_CR24","doi-asserted-by":"publisher","first-page":"2004940","DOI":"10.1002\/adfm.202004940","volume":"30","author":"N Wang","year":"2020","unstructured":"Wang, N. et al. Multistage sensitive NanoCRISPR enable efficient intracellular disruption of immune checkpoints for robust innate and adaptive immune coactivation. Adv. Funct. Mater. 30, 2004940 (2020).","journal-title":"Adv. Funct. Mater."},{"key":"1518_CR25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nrg3763","volume":"15","author":"H Yin","year":"2014","unstructured":"Yin, H. et al. Non-viral vectors for gene-based therapy. Nat. Rev. Genet. 15, 541\u2013555 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"1518_CR26","doi-asserted-by":"publisher","first-page":"1606628","DOI":"10.1002\/adma.201606628","volume":"29","author":"Q Sun","year":"2017","unstructured":"Sun, Q., Zhou, Z., Qiu, N. & Shen, Y. Rational design of cancer nanomedicine: nanoproperty integration and synchronization. Adv. Mater. 29, 1606628 (2017).","journal-title":"Adv. Mater."},{"key":"1518_CR27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.addr.2020.04.010","volume":"168","author":"X Song","year":"2021","unstructured":"Song, X. et al. Delivery of CRISPR\/Cas systems for cancer gene therapy and immunotherapy. Adv. Drug Deliv. Rev. 168, 158\u2013180 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1518_CR28","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1021\/acs.nanolett.0c00893","volume":"20","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Programmable delivery of immune adjuvant to tumor-infiltrating dendritic cells for cancer immunotherapy. Nano Lett. 20, 4882\u20134889 (2020).","journal-title":"Nano Lett."},{"key":"1518_CR29","doi-asserted-by":"publisher","first-page":"17543","DOI":"10.1073\/pnas.2005794117","volume":"117","author":"CE Callmann","year":"2020","unstructured":"Callmann, C. E. et al. Tumor cell lysate-loaded immunostimulatory spherical nucleic acids as therapeutics for triple-negative breast cancer. Proc. Natl Acad. Sci. USA 117, 17543\u201317550 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1518_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nri1329","volume":"4","author":"DM Klinman","year":"2004","unstructured":"Klinman, D. M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4, 249\u2013258 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"1518_CR31","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1089\/dna.2019.5324","volume":"39","author":"T Nakano","year":"2020","unstructured":"Nakano, T. et al. Double-stranded structure of the polyinosinic-polycytidylic acid molecule to elicit TLR3 signaling and adjuvant activity in murine intranasal A(H1N1) pdm09 influenza vaccination. DNA Cell Biol. 39, 1730\u20131740 (2020).","journal-title":"DNA Cell Biol."},{"key":"1518_CR32","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1126\/science.1138963","volume":"316","author":"V Mata-Haro","year":"2007","unstructured":"Mata-Haro, V. et al. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316, 1628\u20131632 (2007).","journal-title":"Science"},{"key":"1518_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-019-0269-6","volume":"20","author":"DJ Irvine","year":"2020","unstructured":"Irvine, D. J. & Dane, E. L. Enhancing cancer immunotherapy with nanomedicine. Nat. Rev. Immunol. 20, 321\u2013334 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1518_CR34","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1210\/en.2015-1206","volume":"156","author":"J Lim","year":"2015","unstructured":"Lim, J., Nakamura, B. N., Mohar, I., Kavanagh, T. J. & Luderer, U. Glutamate cysteine ligase modifier subunit (gclm) null mice have increased ovarian oxidative stress and accelerated age-related ovarian failure. Endocrinology 156, 3329\u20133343 (2015).","journal-title":"Endocrinology"},{"key":"1518_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02950-8","volume":"11","author":"N Seiwert","year":"2020","unstructured":"Seiwert, N. et al. Heme oxygenase 1 protects human colonocytes against ROS formation, oxidative DNA damage and cytotoxicity induced by heme iron, but not inorganic iron. Cell Death Dis. 11, 787 (2020).","journal-title":"Cell Death Dis."},{"key":"1518_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41577-020-00491-x","volume":"21","author":"NK Campbell","year":"2021","unstructured":"Campbell, N. K., Fitzgerald, H. K. & Dunne, A. Regulation of inflammation by the antioxidant haem oxygenase 1. Nat. Rev. Immunol. 21, 411\u2013425 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1518_CR37","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.3390\/ijms20153628","volume":"20","author":"Y Kishimoto","year":"2019","unstructured":"Kishimoto, Y., Kondo, K. & Momiyama, Y. The protective role of heme oxygenase-1 in atherosclerotic diseases. Int. J. Mol. Sci. 20, 3628 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1518_CR38","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3390\/ijms22041514","volume":"22","author":"A Yachie","year":"2021","unstructured":"Yachie, A. Heme oxygenase-1 deficiency and oxidative stress: a review of 9 independent human cases and animal models. Int. J. Mol. Sci. 22, 1514 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1518_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08670-8","volume":"10","author":"M Wan","year":"2019","unstructured":"Wan, M. et al. Bio-inspired nitric-oxide-driven nanomotor. Nat. Commun. 10, 966 (2019).","journal-title":"Nat. Commun."},{"key":"1518_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/imr.12432","volume":"272","author":"A Alloatti","year":"2016","unstructured":"Alloatti, A., Kotsias, F., Magalhaes, J. G. & Amigorena, S. Dendritic cell maturation and cross-presentation: timing matters! Immunol. Rev. 272, 97\u2013108 (2016).","journal-title":"Immunol. Rev."},{"key":"1518_CR41","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1021\/nl071542i","volume":"7","author":"Y Hu","year":"2007","unstructured":"Hu, Y. et al. Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. Nano Lett. 7, 3056\u20133064 (2007).","journal-title":"Nano Lett."},{"key":"1518_CR42","doi-asserted-by":"publisher","first-page":"7749","DOI":"10.1073\/pnas.1332767100","volume":"100","author":"G Lugo-Villarino","year":"2003","unstructured":"Lugo-Villarino, G., Maldonado-Lopez, R., Possemato, R., Penaranda, C. & Glimcher, L. H. T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc. Natl Acad. Sci. USA 100, 7749\u20137754 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1518_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.imlet.2004.05.003","volume":"94","author":"J Pan","year":"2004","unstructured":"Pan, J. et al. Interferon-gamma is an autocrine mediator for dendritic cell maturation. Immunol. Lett. 94, 141\u2013151 (2004).","journal-title":"Immunol. Lett."},{"key":"1518_CR44","doi-asserted-by":"publisher","first-page":"925135","DOI":"10.1155\/2012\/925135","volume":"2012","author":"RV Luckheeram","year":"2012","unstructured":"Luckheeram, R. V., Zhou, R., Verma, A. D. & Xia, B. CD4+ T cells: differentiation and functions. Clin. Dev. Immunol. 2012, 925135 (2012).","journal-title":"Clin. Dev. Immunol."},{"key":"1518_CR45","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","volume":"18","author":"J Borst","year":"2018","unstructured":"Borst, J., Ahrends, T., Babala, N., Melief, C. J. M. & Kastenmuller, W. CD4+ T cell help in cancer immunology and immunotherapy. Nat. Rev. Immunol. 18, 635\u2013647 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1518_CR46","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","volume":"18","author":"DB Doroshow","year":"2021","unstructured":"Doroshow, D. B. et al. PD-L1 as a biomarker of response to immune-checkpoint inhibitors. Nat. Rev. Clin. Oncol. 18, 345\u2013362 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1518_CR47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","volume":"175","author":"MF Sanmamed","year":"2018","unstructured":"Sanmamed, M. F. & Chen, L. A paradigm shift in cancer immunotherapy: from enhancement to normalization. Cell 175, 313\u2013326 (2018).","journal-title":"Cell"},{"key":"1518_CR48","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrclinonc.2017.194","volume":"15","author":"JG Hiller","year":"2018","unstructured":"Hiller, J. G., Perry, N. J., Poulogiannis, G., Riedel, B. & Sloan, E. K. Perioperative events influence cancer recurrence risk after surgery. Nat. Rev. Clin. Oncol. 15, 205\u2013218 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1518_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03915-4","volume":"9","author":"T Wang","year":"2018","unstructured":"Wang, T. et al. A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors. Nat. Commun. 9, 1532 (2018).","journal-title":"Nat. Commun."},{"key":"1518_CR50","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","volume":"21","author":"KJ Hiam-Galvez","year":"2021","unstructured":"Hiam-Galvez, K. J., Allen, B. M. & Spitzer, M. H. Systemic immunity in cancer. Nat. Rev. Cancer 21, 345\u2013359 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"1518_CR51","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.chembiol.2016.10.012","volume":"23","author":"L Xia","year":"2016","unstructured":"Xia, L., Schrump, D. S. & Gildersleeve, J. C. Whole-cell cancer vaccines induce large antibody responses to carbohydrates and glycoproteins. Cell Chem. Biol. 23, 1515\u20131525 (2016).","journal-title":"Cell Chem. Biol."},{"key":"1518_CR52","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1158\/2326-6066.CIR-19-0545","volume":"8","author":"A Pavlick","year":"2020","unstructured":"Pavlick, A. et al. Combined vaccination with NY-ESO-1 protein, poly-ICLC, and montanide improves humoral and cellular immune responses in patients with high-risk melanoma. Cancer Immunol. Res. 8, 70\u201380 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"1518_CR53","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1126\/science.aav8692","volume":"365","author":"L Ma","year":"2019","unstructured":"Ma, L. et al. Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor. Science 365, 162\u2013168 (2019).","journal-title":"Science"},{"key":"1518_CR54","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1172\/JCI99538","volume":"129","author":"F Chen","year":"2019","unstructured":"Chen, F. et al. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors. J. Clin. Invest. 129, 2056\u20132070 (2019).","journal-title":"J. Clin. Invest."},{"key":"1518_CR55","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.vaccine.2016.05.073","volume":"35","author":"X Zhang","year":"2017","unstructured":"Zhang, X., Sharma, P. K., Peter Goedegebuure, S. & Gillanders, W. E. Personalized cancer vaccines: targeting the cancer mutanome. Vaccine 35, 1094\u20131100 (2017).","journal-title":"Vaccine"},{"key":"1518_CR56","doi-asserted-by":"publisher","first-page":"349","DOI":"10.5582\/bst.2020.03267","volume":"14","author":"C Sun","year":"2020","unstructured":"Sun, C. & Xu, S. Advances in personalized neoantigen vaccines for cancer immunotherapy. Biosci. Trends. 14, 349\u2013353 (2020).","journal-title":"Biosci. Trends."},{"key":"1518_CR57","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1158\/1078-0432.CCR-15-1509","volume":"22","author":"O Tureci","year":"2016","unstructured":"Tureci, O. et al. Targeting the heterogeneity of cancer with individualized neoepitope vaccines. Clin. Cancer Res. 22, 1885\u20131896 (2016).","journal-title":"Clin. Cancer Res."},{"key":"1518_CR58","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2217\/imt-2016-0146","volume":"9","author":"CA Brennick","year":"2017","unstructured":"Brennick, C. A., George, M. M., Corwin, W. L., Srivastava, P. K. & Ebrahimi-Nik, H. Neoepitopes as cancer immunotherapy targets: key challenges and opportunities. Immunotherapy 9, 361\u2013371 (2017).","journal-title":"Immunotherapy"},{"key":"1518_CR59","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1703449","volume":"9","author":"I Vanmeerbeek","year":"2020","unstructured":"Vanmeerbeek, I. et al. Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. Oncoimmunology 9, 1703449 (2020).","journal-title":"Oncoimmunology"},{"key":"1518_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03221-2","volume":"11","author":"J Fucikova","year":"2020","unstructured":"Fucikova, J. et al. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death Dis. 11, 1013 (2020).","journal-title":"Cell Death Dis."},{"key":"1518_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11269-8","volume":"10","author":"W Li","year":"2019","unstructured":"Li, W. et al. Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death. Nat. Commun. 10, 3349 (2019).","journal-title":"Nat. Commun."},{"key":"1518_CR62","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan, N., Baselga, J. & Hyman, D. M. A view on drug resistance in cancer. Nature 575, 299\u2013309 (2019).","journal-title":"Nature"},{"key":"1518_CR63","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41565-020-00793-0","volume":"16","author":"S Shen","year":"2021","unstructured":"Shen, S. et al. A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells. Nat. Nanotechnol. 16, 104\u2013113 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"1518_CR64","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcancer.2016.11.006","volume":"42","author":"D Wu","year":"2017","unstructured":"Wu, D. et al. Roles of tumor heterogeneity in the development of drug resistance: a call for precision therapy. Semin Cancer Biol. 42, 13\u201319 (2017).","journal-title":"Semin Cancer Biol."},{"key":"1518_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25391-z","volume":"12","author":"AL Chin","year":"2021","unstructured":"Chin, A. L. et al. Implantable optical fibers for immunotherapeutic delivery and tumor impedance measurement. Nat. Commun. 12, 5138 (2021).","journal-title":"Nat. Commun."},{"key":"1518_CR66","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1097\/j.pain.0000000000000968","volume":"158","author":"VK Samineni","year":"2017","unstructured":"Samineni, V. K. et al. Fully implantable, battery-free wireless optoelectronic devices for spinal optogenetics. Pain 158, 2108\u20132116 (2017).","journal-title":"Pain"},{"key":"1518_CR67","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.1002\/adma.201300583","volume":"25","author":"L Xu","year":"2013","unstructured":"Xu, L. et al. Morphologically virus-like fullerenol nanoparticles act as the dual-functional nanoadjuvant for HIV-1 vaccine. Adv. Mater. 25, 5928\u20135936 (2013).","journal-title":"Adv. Mater."},{"key":"1518_CR68","doi-asserted-by":"publisher","first-page":"100961","DOI":"10.1016\/j.xpro.2021.100961","volume":"2","author":"C Grosjean","year":"2021","unstructured":"Grosjean, C. et al. Isolation and enrichment of mouse splenic T cells for ex vivo and in vivo T cell receptor stimulation assays. STAR Protoc. 2, 100961 (2021).","journal-title":"STAR Protoc."},{"key":"1518_CR69","doi-asserted-by":"crossref","unstructured":"Wang, N. A HO-1 gene knockout using a NanoCRISPR scaffold suppresses metastasis in mouse models. NCBI SRA https:\/\/www.ncbi.nlm.nih.gov\/sra\/PRJNA1290303 (2025).","DOI":"10.1038\/s41551-026-01854-w"}],"updated-by":[{"DOI":"10.1038\/s41551-026-01854-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:00:00Z","timestamp":1794355200000}}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01518-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01518-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01518-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:04:04Z","timestamp":1794470644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01518-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":69,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1518"],"URL":"https:\/\/doi.org\/10.1038\/s41551-025-01518-1","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"12 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41551-026-01854-w","URL":"https:\/\/doi.org\/10.1038\/s41551-026-01854-w","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}